Results 151 to 160 of about 15,493 (219)

Ageing Signatures and Disturbed Muscle Regeneration in Muscle Proteome of Inclusion Body Myositis. [PDF]

J Cachexia Sarcopenia Muscle
de Vries GM, Asselbergh B, Monticelli A, De Jonghe P, Maudsley S, Van Den Bergh PYK, Bigot A, De Bleecker JL, Ermanoska B, De Ridder W, Baets J.   +10 more
europepmc   +1 more source

Inclusion body myositis and immunosenescence: current evidence and future perspectives. [PDF]

Rheumatology (Oxford)
Allameen NA, Salam S, Reddy V, Machado PM.   +3 more
europepmc   +1 more source

Mitochondria-centred metabolomic map of inclusion body myositis: sex-specific alterations in central carbon metabolism. [PDF]

Ann Rheum Dis
Naddaf E, Shammas I, Dasari S, Petterson XT, Springer W, Trushina E, Lanza IR.   +6 more
europepmc   +1 more source

Reply to Owais Et al. Concerns Regarding "Small Fiber Morphology and Function in Inclusion Body Myositis-A Multimodal Assessment Including Confocal Corneal Microscopy". [PDF]

Eur J Neurol
Sturm D, Güttsches AK, Vorgerd M, Schwenkreis P, Westermann A, Greiner T, Vollert J, Eitner L, Maier C, Forsting J, Enax-Krumova E.   +10 more
europepmc   +1 more source

Efficacy and safety of pharmacological treatments in inclusion body myositis: a systematic review. [PDF]

RMD Open
Santos EJF, Farisogullari B, Yapp N, Townsley H, Sousa P, Machado PM.   +5 more
europepmc   +1 more source

A fatal case of disseminated microsporidiosis due to Anncaliia algerae in a renal and pancreas allograft recipient [PDF]

, 2019
Anderson, Neil W, Arif, Sana, Bruminhent, Jackrapong, Deziel, Paul J, Metcalfe, Maureen G, Muehlenbachs, Atis, Pritt, Bobbi S, Qvarnstrom, Yvonne, Razonable, Raymund R, Wilhelm, Mark P   +9 more
core   +1 more source

Altered Transcriptome Signature in Primary Human Myotubes Exposed to Inclusion Body Myositis Serum: A Pilot Case Comparison of Anti-cN1A Positive and Negative Sera. [PDF]

Muscles
Slater N, Chopra A, Ram R, Adams A, Mastaglia FL, Needham M, Coudert JD.   +6 more
europepmc   +1 more source

Reply to: "Before Coming to the Conclusion That Inclusion Body Myositis Is a Risk Factor for a Heart Attack, All Influencing Factors Must Be Taken Into Account". [PDF]

Eur J Neurol
Naddaf E.
europepmc   +1 more source

NLRP3 Inflammasome Activation and Altered Mitophagy Are Key Pathways in Inclusion Body Myositis. [PDF]

J Cachexia Sarcopenia Muscle
Naddaf E, Nguyen TKO, Watzlawik JO, Gao H, Hou X, Fiesel FC, Mandrekar J, Kokesh E, Harmsen WS, Lanza IR, Springer W, Trushina E.   +11 more
europepmc   +1 more source